US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      TOYOTA ( 22V445000 )

      Dated: JUN 23, 2022 Toyota Motor Engineering & Manufacturing (Toyota) is recalling certain 2022 Tundra and Tundra Hybrid vehicles. The flange nuts on … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / Tasigna – Atherosclerosis

Tasigna – Atherosclerosis

May 11, 2018 By US Recall News Leave a Comment

Chemotherapy

Tasigna (nilotinib) is a chemotherapy drug originally approved to treat Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Tasigna can have serious and life-threatening side effects, including the development of atherosclerosis. When the drug was approved by the U.S. Food and Drug Administration (FDA) in 2007, it carried warnings for some of the serious side effects, but no warning about atherosclerosis. In 2013, a warning about the danger was issued in Canada, but no such warning letter was issued in the U.S.

Studies Show Atherosclerosis Risk

Numerous studies have found a link between Tasigna use and atherosclerosis, nine of which were published in 2013 alone. One of the 2013 studies was an FDA postmarket review. The agency stated that the study “strongly suggest an association between nilotinib (Tasigna) and PAOD (peripheral arterial occlusive disease)”. That year, a warning letter was sent to doctors in Canada, but not in the U.S.

Dangers of Atherosclerosis

Atherosclerosis is a very serious health condition which can have life-threatening or fatal complications. Dangers of atherosclerosis include:

  • Coronary heart disease
  • Peripheral artery disease
  • Carotid artery disease
  • Heart attack
  • Stroke
  • Embolic occlusion
  • Circulatory problems leading to gangrene and amputation
  • Chronic kidney disease

Other Serious Side Effects

Tasigna can also have other very serious side effects including:

  • Pancreatitis
  • Liver problems
  • Tumor lysis syndrome (TLS)
  • Kidney problems
  • Low blood count
  • Bleeding in the brain
  • Decreased blood flow to the brain, heart, or leg
  • QT prolongation
  • Sudden death

If you believe that your injuries or the death of a loved one was caused but Tasigna, please talk to an experienced defective drug attorney right away to learn more about your rights and potential compensation.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Drug Recalls, Tasigna

About US Recall News

US Recall News provides recall news and information to the United States general public. Find all of the latest drug, food, products, and vehicle recall news as reported by U.S. government agencies and more.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

TOYOTA ( 22V445000 )

June 29, 2022 By NHTSA

FREIGHTLINER ( 22V443000 )

June 29, 2022 By NHTSA

GRAND DESIGN ( 22V442000 )

June 29, 2022 By NHTSA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up

June 28, 2022 By The FDA

THOMAS BUILT BUSES ( 22V441000 )

June 28, 2022 By NHTSA

THOMAS BUILT BUSES ( 22V438000 )

June 28, 2022 By NHTSA

NISSAN ( 22V420000 )

June 28, 2022 By NHTSA

FCCC ( 22V439000 )

June 28, 2022 By NHTSA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

NISSAN ( 22V420000 )

June 28, 2022 By NHTSA

FCCC ( 22V439000 )

June 28, 2022 By NHTSA

URAL ( 22V431000 )

June 25, 2022 By NHTSA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • TOYOTA ( 22V445000 )
  • FREIGHTLINER ( 22V443000 )
  • GRAND DESIGN ( 22V442000 )
  • GMC ( 22V446000 )
  • KIA ( 22V447000 )
  • Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
  • THOMAS BUILT BUSES ( 22V441000 )
  • THOMAS BUILT BUSES ( 22V438000 )
  • NISSAN ( 22V420000 )
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2022 Altrumedia · Terms of Service · Log in